It seems that the known therapy escape factor TGF-β1 [46] might render HPV− HNSCC cells responsive to growth factors such as EGF, FGF, NGF or BDNF, which support expansion of cell clones that survive therapeutic interventions. The gene discussed is TGFB1; the disease is head and neck squamous cell carcinoma.